Fort Dodge, IA January 6, 2021 – CJ BIO today announced the completion of an additional increment of threonine capacity at the company’s U.S. Fort Dodge, Iowa plant. CJ announced in August of 2020 the completion of the FDA evaluation for Thr Pro, an 80% active granular source of L-threonine, with residual biomass.
“Initial plant capacity was twenty thousand metric tons which required an investment of $50 million. Through process enhancements, additional permitting, and efficiency improvements, our team is now producing at thirty thousand metric tons per year,” commented Joe Lucas, Vice President and GM – Animal Nutrition and Health at CJ America. “Based on the commercial acceptance of Thr Pro, we are also pleased to announce approval for an additional twenty thousand metric tons of capacity, which we will bring on stream in the second quarter of 2022. We will invest another $20 million over the next eighteen months to achieve a total threonine capacity of 50 thousand metric tons. The investment will also allow CJ to begin valine production at the Fort Dodge plant,” added Lucas.
“We are committed to continue the expansion of our North America operations in the state of Iowa to optimize efficient operations and better serve customers,” added Harry Jang, Head of CJ BIO for North and South America.
CJ BIO is a division of CJ CheilJedang, a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. CJ Group has developed its business portfolio into four core sectors – Food & Food Service, Bio & Pharma, Entertainment & Media, and Retail & Logistics.
CJ Biomaterials, Inc., a division of South Korea-based CJ CheilJedang, generated significant interest in its polyhydroxyalkanoate (PHA) technology at the 7th International Marine Debris Conference (IMDC), held September 19-23 at the Busan Exhibition and Convention Center in Busan, South Korea.
More DetailsCJ BIO has signed a Memorandum of Understanding (MOU) with the global hotel chain Accor to begin developing hotel amenities that are made with polyhydroxyalkanoate (PHA), an eco-friendly biodegradable material. Through this agreement, the two companies will work together to replace single-use plastic amenities that are provided to all Accor hotel guests, which will help the hotel chain to deliver on its commitment to phase out all single-use plastic items in guest experience from its hotels by the end of 2022.
More DetailsCJ CheilJedang will invest $210 million to expand manufacturing facilities at its amino acid plant in Brazil. The investment will be used to expand manufacturing facilities of its plant in Piracicaba, Sao Paulo, which is operated by CJ DO Brasil, a subsidiary 99.99 percent owned by CJ CheilJedang.
More DetailsCJ BIO announced today that marine biodegradability testing of its environmentally friendly amorphous polyhydroxyalkanoate (PHA) material conducted by the Korea Conformity Laboratories (KCL) showed weight loss of 57% after just 11 weeks, demonstrating the polymer’s ability to quickly biodegrade in the natural environment.
More DetailsCJ Bio America is truly a good corporate citizen. It produces quality products that have a beneficial impact on the nation’s food supply. It employs local people and does business with local companies. And if that isn’t enough, it pitches in in various ways to make the community a better place to live.
More DetailsTwo employees from CJ Bio America came to volunteer at the barbecue. June 25 is a significant date for South Koreans — it marks the anniversary of the North Korean army invading South Korea, setting off the Korean War. Sahngho Lee, purchasing manager at CJ Bio America, said he feels a lot of appreciation for American veterans.
More DetailsCJ Bio’s most recent investment, a $20 million expansion of its plant to produce amino acids for livestock feed, was celebrated Friday at a ribbon cutting with company executives, employees and local community leaders.
More DetailsIn an effort to upgrade biological recycling technologies that can replace mechanical recycling, CJ Cheil Jedang will work with a national university research team to develop and commercialize high-efficiency enzymes that biologically decompose plastics.
More DetailsCJ BIO, a division of South Korea-based CJ CheilJedang and leading producer of polyhydroxyalkanoate (PHA), and NatureWorks, an advanced materials company that is the world’s leading producer of polylactic acid (PLA), have signed a letter of intent (LOI) establishing a strategic alignment between the two organizations and have announced that the two companies are working toward a Master Collaboration Agreement (MCA). The companies will work together to develop sustainable materials solutions based on CJ BIO’s PHACT® Marine Biodegradable Polymers and NatureWorks’ Ingeo™ biomaterials technology.
More DetailsCJ BIO has introduced PHACT® Marine Biodegradable Polymers based on its proprietary polyhydroxyalkanoate (PHA) technology. Being a part of the solution to change the trajectory of the plastic pollution challenge and preserving the planet is the essence of the PHACT brand. PHACT means (PHA + Act) and CJ Bio is committed to impactful action delivering eco-friendly solutions with their extensive PHA technology platform.
More Details